Pharmaceutical companies are leveraging their proprietary internal data to significantly improve AI models designed for protein folding. This private data has proven more effective than publicly available datasets in advancing these models. The initiative aims to create a public database of genetic mutations, potentially accelerating drug discovery and development. AI
IMPACT Enhances AI capabilities in drug discovery and development by utilizing private datasets for protein folding models.
RANK_REASON The item discusses advancements in AI models for a scientific domain (protein folding) using proprietary data, which aligns with research advancements. [lever_c_demoted from research: ic=1 ai=1.0]
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →